Hologic, Inc. (NASDAQ:HOLX) CFO Karleen Marie Oberton sold 1,312 shares of the company’s stock in a transaction that occurred on Thursday, November 8th. The stock was sold at an average price of $41.90, for a total value of $54,972.80. Following the transaction, the chief financial officer now owns 10,206 shares of the company’s stock, valued at $427,631.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Karleen Marie Oberton also recently made the following trade(s):
- On Tuesday, November 6th, Karleen Marie Oberton sold 546 shares of Hologic stock. The stock was sold at an average price of $39.96, for a total value of $21,818.16.
Shares of NASDAQ HOLX traded down $0.68 during trading hours on Friday, reaching $41.78. The stock had a trading volume of 2,607,170 shares, compared to its average volume of 1,970,584. The company has a current ratio of 1.29, a quick ratio of 0.99 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $11.23 billion, a price-to-earnings ratio of 18.74, a PEG ratio of 1.88 and a beta of 0.65. Hologic, Inc. has a twelve month low of $35.10 and a twelve month high of $45.09.
A number of research analysts have recently commented on the company. Needham & Company LLC upped their price target on Hologic from $43.00 to $48.00 and gave the stock a “buy” rating in a report on Wednesday, August 1st. BidaskClub upgraded Hologic from a “hold” rating to a “buy” rating in a report on Wednesday, August 1st. Deutsche Bank upped their price target on Hologic from $42.00 to $45.00 and gave the stock a “hold” rating in a report on Wednesday, August 1st. Canaccord Genuity reiterated a “hold” rating and set a $43.00 price target on shares of Hologic in a report on Thursday. Finally, Zacks Investment Research upgraded Hologic from a “sell” rating to a “hold” rating in a report on Thursday, August 2nd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eight have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $44.41.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Piedmont Investment Advisors LLC acquired a new position in shares of Hologic in the second quarter valued at $127,000. Bessemer Group Inc. raised its stake in shares of Hologic by 122.4% in the third quarter. Bessemer Group Inc. now owns 3,534 shares of the medical equipment provider’s stock valued at $145,000 after purchasing an additional 1,945 shares in the last quarter. Amussen Hunsaker Associates LLC acquired a new position in shares of Hologic in the second quarter valued at $159,000. Stratos Wealth Partners LTD. acquired a new position in shares of Hologic in the third quarter valued at $185,000. Finally, Lincoln Capital Corp acquired a new position in shares of Hologic in the third quarter valued at $201,000. Institutional investors and hedge funds own 98.74% of the company’s stock.
WARNING: “Hologic, Inc. (HOLX) CFO Karleen Marie Oberton Sells 1,312 Shares” was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.com-unik.info/2018/11/10/hologic-inc-holx-cfo-karleen-marie-oberton-sells-1312-shares.html.
Hologic Company Profile
Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.
Featured Article: Why investors pay attention to retained earnings
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.